12 Articles
12 Articles
FDA reverses course and will review Moderna’s mRNA-based flu vaccine
US drug regulator originally refused to consider application, fueling critics’ concern about alleged ‘anti-vaccine agenda’The Food and Drug Administration (FDA) reversed course on Wednesday and will now review Moderna’s application for the first mRNA-based flu vaccine after initially declining to consider it.Moderna announced that the US drug regulator will move forward with reviewing its updated flu vaccine application. The decision comes only …
Coverage Details
Total News Sources12
Leaning Left5Leaning Right0Center6Last UpdatedBias Distribution55% Center
Bias Distribution
- 55% of the sources are Center
55% Center
L 45%
C 55%
Factuality
To view factuality data please Upgrade to Premium


